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Abstract
Neuroinflammation,  characterized  by  the  appearance  of  reactive  microglial  and  astroglial  cells,  is  one  of  the
several  pathogenic  mechanisms  of  amyotrophic  lateral  sclerosis  (ALS),  a  fast-progressing  and  fatal
neurodegenerative disease. Cerebrospinal fluid and spinal cord of ALS patients and SOD1 mutant mice show high
concentrations of IL-1β. This interleukin, expressed as an inactive precursor, undergoes a proteolytic maturation
by caspase1, whose activation, in turn, depends on inflammasomes. Whether and how inflammasome is activated
in  ALS  models  is  still  to  be  clarified.  The  mechanism  of  inflammasome  activation  was  studied  in  murine
microglial  cells  overexpressing  hSOD1(G93A) and verified in  the  spinal  cord of  hSOD1(G93A) mice.  Murine
microglial hSOD1(G93A) cells express all the inflammasome components and LPS activates caspase1 leading to
an increase in the secretion of IL-1β. By activating NF-κB, LPS increases ROS and NO levels that spontaneously
react to form peroxynitrite, thus leading to protein nitration. Reduction in peroxynitrite levels results in a decrease
in  caspase1  activity.  Protein  nitration  and  caspase1  activity  are  concomitantly  increased  in  the  spinal  cord  of
pre-symptomatic  SOD1(G93A) mice. Oxidative/nitrosative stress induces peroxynitrite formation that may be a
key  trigger  of  caspase1/inflammasome  activation.  Peroxynitrite  formation  may  play  a  critical  role  in
inflammasome activation and might be exploited as potential therapeutic target for ALS.
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Introduction
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Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by a fast-progressing motor neuron
death. Usually, patients show severe muscle atrophy, paralysis and ultimately denervation of respiratory muscles and
surrender to the disease within 2–5 years from the clinical onset [ 1 ]. Most of the ALS cases are classified as
sporadic, since there is no family history of the disease. The remaining few cases (5–10%) are defined as familial
since inherited in an autosomal dominant fashion. These two forms of ALS are clinically indistinguishable,
notwithstanding the genetic differences. Almost 20% of familial cases are connected with mutations in the
superoxide dismutase 1 (SOD1) gene [ 2 ], such as the substitution of glycine to alanine in position 93 (G93A).
hSOD1(G93A) transgenic mice, which undergo a gradually progressive disease, are used as the gold standard in ALS
research.
Non-cell autonomous mechanisms involving non-neuronal cells contribute to motor neuron death [ 3 ], suggesting
that multiple damages, occurring in multiple cellular compartments, can ultimately lead to the neuromuscular failure,
the main feature of ALS.
The reduction of mutant SOD1 in microglia extends survival in transgenic SOD1(G37R) mice and supports the
hypothesis of the contribution of non-neuronal cell toxicity to the pathogenesis of the disease [ 4 ]. Therefore, it is
accepted that the microglial compartment is one of the non-cell autonomous player in the killing of motor neurons
[ 5 ].
Indeed, the appearance of activated microglial and astroglial cells, a process known as neuroinflammation,
characterizes ALS. Furthermore, in transgenic mouse models of mutant SOD1-associated familial ALS, the loss of
motor neurons follows the appearance of activated microglial cells [ 6, 7 ], thus underpinning the fundamental role of
microglial cells in the phenotype development.
Microglia are macrophage-like cells performing the main active immune defense towards infection or injury in the
central nervous system (CNS). Because of these functions, microglia display a range of pattern recognition receptors
(PRRs) and produce a few important pro-inflammatory mediators, such as tumor necrosis factor (TNF)α and
interleukin 1β (IL-1β) [ 6 ], thus taking part in the inflammatory responses to stimuli. Since ALS pathogenesis is
underpinned by a vicious cycle of inflammation and neurodegeneration, the ability of microglial cells to trigger and
maintain chronic inflammation has strengthen its pivotal role in the disease [ 6, 7, 8 ]. For instance, in the CNS of
ALS patients and mutant SOD1 transgenic mice, elevated levels of IL-1β were found [ 9 ]. However, it is still unclear
the cellular source of this IL-1β or the stimulus that drives its expression. IL-1β is expressed as an inactive precursor
which, to be activated, has to undergo a proteolytic processing by caspase1. Caspase1, in turn, is bound to and
activated by a multiprotein complex, to form the inflammasome. A range of substances that arise during infections,
tissue damage or metabolic imbalance causes the inflammasome formation.
Commonly, inflammasomes are composed by three elements: a cytosolic PRR, pro-caspase1 and a PRR-specific
adaptor molecule. The best-characterized inflammasome forming PRR is NOD-like receptor pyrin domain containing
three (NLRP3) [ 10, 11 ]. NLRP3, activated by a wide range of molecules related to damage or infection,
oligomerizes with the adaptor ASC (apoptosis-associated speck-like protein containing a caspase recruitment
domain) and caspase1 to form the NLRP3-inflammasome, which leads to the processing of pro- to mature IL-1β and
its release. Although the likely importance of IL-1β in ALS and the potential capacity of NLRP3 to associate
inflammation to IL-1β production, relatively few studies have surveyed the link between ALS and NLRP3
[ 12, 13, 14, 15 ].
In this study, we investigated the inflammasome activation in the spinal cord of hSOD1(G93A) mice and in murine
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=vkL656d...
2 di 15 24/03/2017 10:49
microglial cells overexpressing hSOD1(G93A) and hypothesized that, by activating NLRP3 in glial cells,
inflammation-induced peroxynitrite could drive chronic inflammation in the context of ALS.
Materials and Methods
Materials
All the reagents, unless otherwise stated, were from Sigma-Aldrich (St. Louis, MO). All the antibodies, unless
otherwise stated, were from Santa Cruz Biotech (Santa Cruz, CA). Cell culture reagents were from Life
Technologies (GibcoBRL, Gaithersburg, MD).
Mice
Thirteen-week-old (W13) female C57BL/6 and SOD1(G93A) mice were treated in strict accordance to the guidelines
of the Institutional Animal Care and Use Committee and to National and European legislation, throughout the
experiments. LPS (5 mg/kg) was administered i.p., and animals were killed after 24 h.
Immortalized Microglia
Immortalized microglial cells, obtained from embryonic (E14) cortices from non-transgenic and transgenic
hSOD1(G93A) mice following the method described by Righi and colleagues [ 16 ], were a kind gift of Dr. G.
Pietrini (Università di Milano). Microglia were characterized by Western Blot and immunofluorescence for the
presence of selective markers (CSF-1) and the absence of astrocyte-specific molecules (i.e., glial fibrillary acidic
protein).
Cell Cultures and Treatments
Non-transgenic and SOD1(G93A) microglial cells were cultured in DMEM F-12 supplemented with 5% fetal bovine
serum (FCS), glutamine (4 mM), penicillin (50 U/ml) and streptomycin (50 mg/ml) at 37 °C in a humidified 5% CO
environment and seeded at the density of 31.00094,000/cm . After a 24-h subculture, cells were exposed to 1 μg/ml
LPS for various time. When inhibitors were used, 1400 W (iNOS inhibitor) and apocynin (APO, NOX2 inhibitor),
were added to SOD1(G93A) cells 30 min prior to 1 μg/ml LPS exposure.
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Measurement of NO Production
Nitric oxide (NO) production was determined indirectly through the measurement of nitrite, a stable metabolite of
nitric oxide, by Griess reaction [ 17 ]. Results were expressed as percentage of the control, assumed as 100%. Nitrite
standard reference curve was prepared for each determination.
Measurement of Cytokine Levels by ELISA
Cytokine production was measured with an enzyme-linked immunosorbent assay (ELISA) kit in cell medium
collected from control and LPS-treated cells. Samples were analyzed according to the manufacturer’ s protocols (BD
Biosciences Pharmigen, San Diego, CA).
RT-PCR
Total RNA was isolated with TRIZOL Reagent (Invitrogen Ltd., Paisley, UK) according to the manufacturer’s
instructions, and complementary DNA (cDNA) was synthesized using iScript cDNA synthesis kit (Bio-Rad Lab,
Hercules, CA). PCR products from synthetized cDNA were amplifield with specific mouse primer sequences
obtained from Invitrogen (Invitrogen Ltd., Paisley, UK) and listed in Table 1 . Two microliters of cDNA was used for
each PCR reaction using Taq DNA polymerase (New England Biolabs, Whitby, ON, Canada), according to the
manufacturer’s protocol. The products were visualized on ethidium bromide-stained 1.8% agarose gels.
Table 1
List of primers
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Glyceraldehyde-3-phosphate-dehydrogenase Gapdh F: GCCAAATTCAACGGCACAGT
22
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R: AGATGGTGATGGGCTTCCC
Interleukin 1beta IL1β
F: AAAAGCCTCGTGCTGTCGGACC
R: TTGAGGCCCAAGGCCACAGGT
Interleukin 6 IL6
F: GCTGGAGTCACAGAAGGAGTGGC
R: GGCATAACGCACTAGGTTTGCCG
Tumor necrosis factor alpha Tnfα
F: GCCCACGTCGTAGCAAACCAC
R: GGCTGGCACCACTAGTTGGTTGT
NLR family, pyrin domain containing 1A Nlrp1a
F: CTTGAGAAGTTGGGTGGGGT
R: GATGGAGCAACTCAGGACCA
NLR family, pyrin domain containing 3 NLRP3
F: GACACGAGTCCTGGTGACTTT
R: CAGACGTATCTGAGCCAT
NLR family, CARD domain containing 4 IPAF
F: TCAGGTCACAGAAGACCT
R: TTCACCCAGGGGGTAGAAGT
Absent in melanoma 2 Aim2
F: AAAACTGCTCTGCTGCCTCT
R: GATGGCTTCCTGTTCTGCCA
PYD and CARD domain containing Asc
F: AACTGCGAGAAGGCTATGGG
R: TGAGCTCCAAGCCATACGAC
Heme-binding membrane glycoprotein gp91phox gp91phox
F: TCACCACTAGTACCAGCATCACCA
R: ACTCTGTCTTGCATTTCTGGATGCC
Inducible nitric oxide synthase iNOS
F: GGTGTTCTTTGCTTCCATGCTAAT
R: GTCCCTGGCTAGTGCTTCAGA
Real-Time PCR
Total RNA was isolated with TRIZOL Reagent (Invitrogen Ltd., Paisley, UK) according to the manufacturer’s
instructions, and cDNA was synthesized using iScript cDNA synthesis kit (Bio-Rad Lab, Hercules, CA). Real-time
PCR was performed using the iCycler iQ detection system (Bio-Rad) and SYBR Green chemistry. Mouse primer
sequences, obtained from Invitrogen (Invitrogen Ltd., Paisley, UK) were listed in Table 1 . SYBR Green RT-PCR
amplifications were carried out in a 96-well plate in a 25-μl reaction volume that contained 12.5 μl of 2× iQ™
SYBR® Green SuperMix (Bio-Rad), 400 nM forward and reverse primers and 5 to 40 ng of cDNA. In each assay,
no-template controls were included and each sample was run in triplicates. The thermal profile consisted of
incubation at 95 °C 3 min, followed by 40 cycles of denaturation for 10 s at 95 °C and an annealing/extension step of
30 s at 62 °C. Mean of Ct values of the stimulated sample was compared with the untreated control sample. ΔCt is
the difference in Ct values derived from the target gene (in each assayed sample) and Gpdh, while ΔΔCt represents
the difference between the paired samples. The n-fold differential ratio was expressed as 2 .
Western Blotting Analyses
Non-transgenic and SOD1(G93A) total cell lysate were obtained using hot Laemli sample buffer 1× (60 mM Tris
HCl, pH 6.8, 2% SDS, 10% glycerol, 0.72 M β-mercaptoethanol). Extracts were loaded on SDS-polyacrylamide gel,
transferred on nitrocellulose membrane and immunoblotted with phospho-NF-kB p65 (Ser536) antibody (1:1000)
(Cell Signaling Technology, Danvers, MA), NLRP3 (Cryo-2) antibody (1:1000; AdipoGen Corp., San Diego, CA),
iNOS (M-19) antibody (1:200), caspase1 antibody (1:1500; Cell Signaling Technology, Danvers, MA), gp91 phox
(BD Biosciences Pharmigen, San Diego, CA) antibody (1:2000), IL-1β (1:250; Cell Signaling Technology, Danvers,
MA) and horseradish peroxidase-conjugated anti-IgG antibody (1:5000). GAPDH (6-C5; 1:500) actin (I-19; 1:400)
antibodies were used as marker protein for total extracts and membrane extracts. Immunocomplexes were visualized
with an enhanced chemiluminescence kit (ECL, Pierce Biotechnology, Rockford, IL).
Caspase1 Activity
−ΔΔCt
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Cell pellet from SOD1(G93A) cells were treated with lysis buffer (50 mM HEPES, pH 7.4, 0.1% CHAPS, 0.1 mM
EDTA) and incubated 10 min on ice. After centrifugation, protein extract (50 μg) was incubated with a caspase1
reaction mixture (20 mM PIPES, pH 7.4, 30 mM NaCl, 0.1% CHAPS, 1 mM EDTA, 10% sucrose) containing 50 μM
caspase1 fluorogenic peptide substrate (Ac-YVAD-AFC). Then, elicited fluorescence was recorded (λexc 380 nm
and λem 505 nm). The florescence of AFC (fluorocoumarin) standard solutions (0–5 μM) was used to construct a
calibration curve and caspase1 activity was expressed as pmol of AFC released/min/mg protein.
Measurement of Intracellular Fluorescence
SOD1(G93A) microglial cells, seeded on glass coverslips, were used for evaluation of ROS production, detection of
activate caspase1, immunolocalization of nitrated protein and actin labeling. Lumbar spinal cords (L4–L6) were
dissected, embedded in tissue freezing medium (Leica, Wetzlar, Germany) and frozen in isopentane pre-cooled in
liquid nitrogen. Cryosections of 16 μm thickness were obtained using a Leica cryostat and used to detect activate
caspase1 and immunolocalization of nitrated protein.
ROS Production The 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) method was used to detect ROS
intracellular levels [ 18, 19 ]. The fluorescence of 2′,7′-dichlorofluorescein was detected at 485 nm excitation and at
535 nm emission.
Detection of Activate caspase1 SOD1(G93A) cells were loaded with 50 μM Ac-YVAD-AFC for 1 h at 37 °C and
fixed for 20 min in 4% PFA at room temperature.
Immunolocalization of Nitrated Protein Cells were fixed with 4% PFA for 20 min at room temperature and
incubated overnight at 4 °C with nitrotyrosine antibody (1:50; Sigma-Aldrich, St. Luis, MO).Cells were then
incubated with tetramethylrhodamine (TRITC)-conjugated anti-rabbit IgG (1:100; Jackson ImmunoResearch
Laboratories, INC, PA, USA) for 1 h at room temperature. Control samples were incubated with non-immune serum.
Actin Labeling Phalloidin was used to detect filamentous actin (F-actin) content on SOD1(G93A). The cells were
fixed with 4% PFA for 20 min at room temperature and F-actin was stained with tetramethylrhodamine TRITC-
labeled phalloidin (1:250) for 30 min at room temperature.
At the end of each experimental procedure, cell nuclei were counter-stained with 4′,6-diamidino-2-phenylindole
(DAPI) and samples were analyzed with a Zeiss Axio Observer Z1 equipped with Apotome and Digital Camera
Axiocam MRm Zeiss.
Immunoprecipitation
SOD1(G93A) microglial cells were lysed in RIPA buffer (50 mM Tris HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA,
0.05% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 1 mM PMSF, protease inhibitors) and
immunoprecipitated with nitrotyrosine antibody (1:200) and protein A sepharose. Immunoprecipitated complexes
were washed in lysis buffer and boiled for 5 min in Laemli Sample Buffer 1×. Samples were loaded on
SDS-polyacrylamide gel, transferred on nitrocellulose membrane and immunoblotted with NLRP3 (Cryo-2) antibody
(1:1000) and nitrotyrosine antibody (1:2000).
Statistical Analysis
All results were confirmed in at least three separate experiments and expressed as mean ± SD. Data were analyzed
for statistical significance by Student’s t test. p values <0.05 were considered significant.
Results
LPS Activates NLRP3 Inflammasome in SOD1(G93A) Microglial Cells
Since microglial cells are the key players in neuroinflammatory reactions, to determine the mechanisms leading to
neuroinflammation in ALS, we used immortalized microglial cells from hSOD1(G93A) mice. It has been reported
that the exposure of BV2 microglial cells to exogenous SOD1(G93A)-induced activation of the inflammasome [ 12 ].
Therefore, we sought to determine whether the endogenous expression of SOD1(G93A) could induce the same
effect. We first evaluated the expression of inflammasome components in murine immortalized hSOD1(G93A)
overexpressing microglial cells (SOD1(G93A)) (Fig. 1a ) and found that NLRP1, NLRP3, IPAF and AIM2
inflammasome receptors messenger RNAs (mRNAs) are expressed in SOD1(G93A) cells, together with the
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inflammasome adapter protein ASC, suggesting that, upon stimulation, cells can be able to activate the
inflammasome. Therefore we exposed SOD1(G93A) microglial cells to 1 μg/ml LPS and evaluate the changes in
gene expression of the inflammasome components (Fig. 1b ) and found that a 3-h LPS exposure is sufficient to
increase the expression of the sole NLRP3 inflammasome. This result has been confirmed on protein level (Fig. 1c ).
Indeed, a 6-h LPS exposure caused a robust increase of NLRP3 protein in SOD1(G93A) microglial cells. The
observed increase in NLRP3 expression prompted us to evaluate inflammasome activation. We determined caspase1
activation in SOD1(G93A) microglial cells and found that a 6-h LPS exposure caused an increase in the cleaved
form of caspase1 (Fig. 1d ). To further analyze caspase1 activation in SOD1(G93A) cells, we used the fluorescent
YVAD substrate and found that LPS induced an increase in caspase1-mediated substrate cleavage (Fig. 1e )
corresponding to a doubling of caspase1 specific activity (Fig. 1e ). The addiction of ATP failed to further increase
caspase1 activity (data not shown). The activation of caspase1 through inflammasome results in the secretion of
mature IL-1β [ 11 ]. Indeed, we found that LPS exposure induces a significant increase in IL-1β secretion that is
accompanied by an increase in IL-17 secretion (Fig. 1f ), a direct target of IL-1β in microglial cells [ 20 ]. The
presence of the cleaved form of IL-1β was confirmed by Western blotting (Fig. 1g ). We did not observe any
LPS-induced increase in caspase1 activation in non-transgenic microglial cells (Fig. 1h ). These results suggest that
LPS is capable of activating a functional NLRP3 inflammasome in SOD1(G93A) microglial cells.
Fig. 1
LPS activates NLRP3 inflammasome in SOD1(G93A) microglial cells. Untreated SOD1(G93A) microglial cells were
used for a RT-PCR analysis of inflammasome component expression (1, NLRP1; 2, NLRP3; 3, IPAF-1; 4, AIM2; 5,
ASC); SOD1(G93A) microglial cells were exposed to 1 μg/ml LPS and used for b qRT-PCR of the indicated genes after
a 3-h LPS exposure. Gene expression values were normalized to Gapdh and presented as 2 . Relative mRNA gene
abundance in untreated cells was assumed to be 1 (control). Data represent mean ± SD (n = 3). *p < 0.05 vs. untreated
cells. c Western blotting analysis of NLRP3 and d active caspase1 after 6 h LPS exposure. GAPDH was used as loading
control.  The  images  are  representative  of  one  out  of  three  separate  experiments;  e  detection  of  activated
caspase1/specific enzyme activity assay after a 6-h LPS exposure. Scale bar, 100 μm; f cytokine secretion were assayed
in cell medium by ELISA after an 18-h LPS exposure. Data represent mean ± SD (n = 3). *p < 0.05 vs. untreated cells;
g  Western blotting analysis of IL-1β. h  Non-transgenic microglial  cells  were exposed to 1 μg/ml LPS and used for
Western blotting analysis of active caspase1. The images are representative of one out of three separate experiments.
GAPDH was used as loading control
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LPS Induces Protein Nitration in SOD1(G93A) Microglial Cells
LPS is a toll-like receptor 4 ligand known to induce an inflammatory response in microglial cells [ 21 ]. To test
whether the canonical response is also activated in SOD1(G93A) microglial cells, we first determined the effects of
LPS exposure on cell morphology and found that, in the presence of LPS, cells assume an amoeboid shape
characteristic of microglial activation (Fig. 2a ). Moreover, LPS induces the activation of the transcription factor
NF-κB as detected by the increase in the phosphorylation/activation of the p65 subunit, already after a 3-h exposure
(Fig. 2b ). The activation results in an increase in the expression of several pro-inflammatory genes such as IL-6,
IL-1β, TNFα, (Fig. 2c ), inducible nitric oxide synthase (iNOS) and the gp91phox subunit of NADPH oxydase
(NOX)2 (Fig. 2d , e). The gene expression parallels the increase in cytokine secretion (Fig. 1f ) and the protein
expression (Fig. 2d , e).
Fig. 2
LPS  induces  protein  nitration  in  SOD1(G93A)  microglial  cells.  SOD1(G93A)  microglial  cells  were  treated  with
1 μg/ml LPS. a  Phalloidin staining after  a 24-h exposure. Scale bar,  100 μm; b  time course  of  p-NF-κB.  At  each
indicated  time,  cells  were  collected  and  total  extract  analyzed  by  Western  blotting.  GAPDH  was  used  as  loading
control. The images are representative of one out of three separate experiments; c qRT-PCR of the indicated genes after
a 6-h LPS exposure. Gene expression values were normalized to Gapdh and presented as 2 . Relative mRNA gene−ΔΔCt
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abundance in untreated cells was assumed to be 1 (control). Data represent mean ± SD (n = 4). *p < 0.05 vs. untreated
cells. SOD1(G93A) microglial cells were exposed to 1 μg/ml LPS and used for d,  e  qRT-PCR and Western blotting
analysis of iNOS (d) and gp91 phox (e) at the indicated times. Gene expression values were normalized to Gapdh and
presented as 2 . Relative mRNA gene abundance in untreated cells was assumed to be 1 (control). Data represent
mean ± SD (n = 5). *p < 0.05 vs. untreated cells. GAPDH was used as loading control in Western Blotting analyses.
The images are representative of one out of three separate experiments; f detection of NO production after a 24-h LPS
exposure by Griess Reagent (100% control NO absorbance, 0.29 ± 0.05). *p < 0.05 vs. untreated cells; g detection of
ROS  generation  by  DCF  fluorescence  after  24  h  LPS  exposure.  Scale  bar,  100  μm;  h  immunolocalization  of
nitrotyrosine. The immunofluorescence staining was performed as described using anti-nitrotyrosine antibody after a
6-h LPS exposure. The images are representative of one out of three separate experiments. Scale bar, 100 μm
The activity of iNOS and NOX2 enzymes can be inferred by the observation that the concentration of their products
increases after LPS exposure (Fig. 2f , g). Indeed, LPS induces about a 400% increase in NO levels (Fig. 2f ) and an
increase in ROS levels, as determined by DCFH staining (240 ± 135 vs. 517,860 ± 56,541 pixel over threshold) (Fig.
2g ) and by dihydroethidium staining (Online Resource 1A ). By reacting with NOX2-produced superoxide anion,
NO can form highly reactive peroxynitrite, responsible for protein nitration [ 22 ]. We found that LPS treatment
increases the levels of nitrotyrosine (150 ± 58 vs. 4440 ± 1057 pixel over threshold) (Fig. 2h ) suggesting that
LPS-exposed SOD1(G93A) microglial cells undergo an oxidative/nitrosative stress.
Peroxynitrite Is Responsible for Inflammasome Activation
It has been shown that peroxynitrite is involved in NLRP3 inflammasome activation in intracerebral hemorrhage
−ΔΔCt
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(ICH)-induced inflammatory injury [ 23 ]. To test whether the same mechanism is responsible for LPS-induced
NLRP3 activation in SOD1(G93A) microglial cells, we pre-treated the cells with specific iNOS and NOX2
inhibitors, i.e. 1400W and apocyanin, respectively. 1400W reduced the LPS-induced increase in NO levels (Fig. 3a )
while it did not affect ROS levels (Online Resource 1B ). Apocyanin reduced LPS-induced increase in ROS levels
(3063 ± 380 vs. 1030 ± 118 pixel over threshold) (Fig. 3b ) and NO levels were also affected (Online Resource 1C ).
Both inhibitors reduced nitrotyrosine levels in LPS-treated SOD1(G93A) microglial cells (1400W − 172 ± 28 vs.
1400W + LPS 128 ± 41; APO − 329 ± 72 vs. APO + LPS − 356 ± 94 pixel over threshold) (Fig. 3c ). In the presence
of each single inhibitor, caspase1 activity is strongly reduced (Fig. 3d , e) indicating that LPS induces caspase1
activation in SOD1(G93A) microglial cells through peroxynitrite formation.
Fig. 3
Peroxynitrite  is  responsible  for  inflammasome activation.  SOD1(G93A)  microglial  cells  were  exposed  to  250  μM
1400 W or 500 μM APO prior to 1 μg/ml LPS used for a detection of NO production by Griess Reagent and b detection
of ROS generation by DCF fluorescence (scale bar, 100 μm) after a 24-h LPS exposure. Absorbance of control cells
(0.29 ± 0.05) was assumed as 100%. Data represent mean ± SD (n = 3). *p  < 0.05 vs. control cells; p  < 0.05 vs.
LPS-treated cells; c immunolocalization of nitrotyrosine after a 6-h LPS exposure. Scale bar, 100 μm. SOD1(G93A)
microglial cells, treated with d 250 μM 1400 W or e 500 μM APO prior to a 6-h 1 μg/ml LPS exposure, were collected
and total extracts were subjected to Western blotting. SOD1(G93A) microglial cells were exposed to a 6-h 1 μg/ml LPS
and cell  extracts  were  subjected to  immunoprecipitation (f)  with  anti-  nytrotyrosine  antibody followed by Western
Blotting analysis of NLRP3. The images are representative of one out of three separate experiments. GAPDH was used
as loading control
#
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To determine whether peroxynitrite modifies the NLRP3 inflammasome, we performed immunoprecipitation to
exploreNLRP3 nitration in SOD1(G93A) microglial cells treated with LPS for 6 h (Fig. 3f ). We found that NLRP3
is immunoprecipitated by anti-nitrotyrosine antibody in LPS-treated cells suggesting that this post-translational
modification, induced by the increase in peroxynitrite, could modify NLRP3 function in SOD1(G93A) microglial
cells.
Protein Nitration and Caspase1 Activation Are Increased in the Spinal Cord of
SOD1(G93A) Mice
To determine whether spinal cords of pre-symptomatic hSOD1(G93A) mice display the molecular features of the
mechanism described in vitro, we investigated caspase1 activation and protein nitration in the gray matter of the
lumbar spinal cord of pre-symptomatic (W13) hSOD1(G93A) mice. We found that the spinal cord of ALS mouse
model is robustly stained by the anti-nitrotyrosine antibody (912 ± 400 vs. 14,878 ± 1622 pixel over threshold) (Fig.
4a ) indicating that, even in the pre-symptomatic stage of the pathology, mice undergo a significant increase in
peroxynitrite formation. Moreover, the spinal cord of pre-symptomatic mice shows a strong increase in active
caspase1 (Fig. 4 b). Image analysis of fluorescent signals indicate that caspase1 fluorescence was approximately ten
times higher in SOD1(G93A) compared with control spinal cord (280 ± 148 vs. 2478 ± 504 pixel over threshold).
Moreover, the induction of caspase1 activity was much greater in SOD1(G93A) spinal cord than in 5 mg/kg
LPS-treated control spinal cords. These data indicate that peroxynitrite formation and inflammasome activation are
early concomitant events in ALS pathology and can be, at least in part, responsible for motoneuron cell death.
Fig. 4
Protein nitration and caspase1 activation are increased in the spinal cord of SOD1(G93A) mice. Lumbar spinal cord of
13-week-old untreated (control), LPS-treated (5 mg/kg; LPS) and hSOD1(G93A) (pre-symptomatic) mice were used
for immunolocalization of nytrotyrosine (a) and detection of activate caspase1 (b). The images are representative of
one out of three separate experiments. Scale bar, 100 μm
Discussion
Here we showed, for the first time, that that peroxynitrite activates caspase1 and the downstream inflammatory
cascade in SOD1(G93A) microglial cells thus contributing to one of the several ALS pathogenic mechanisms. To
date, Feng et al. [ 23 ] showed that peroxynitrite is a downstream signaling molecule of P2X7 receptor, which plays a
critical role in triggering NLRP3 inflammasome activation, but by IP we have shown that nitration occurs precisely
at NLRP3 levels. Although the pathogenesis of ALS is believed to involve a vicious circle of inflammation leading
to neurodegeneration and further inflammation, the mechanisms supporting this chronic inflammatory response
remain poorly understood. In this study, we explored the link between protein nitration, resulting from an acute
inflammatory stimulus (LPS), and the activation of the NLRP3 inflammasome as a possible driver of chronicity in
the context of ALS. In glial cells expressing the (G93A) mutant SOD1, we demonstrated that challenge with LPS can
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drive protein nitration-dependent NLRP3 activation. Moreover, we showed that the L4–L6 region of the spinal cord
of pre-symptomatic (W13) SOD1(G93A) mice undergoes massive protein nitration with a concomitant increase in
caspase1 activity, two events which could support our in vitro results. By connecting an acute inflammatory response
to activation of the NLRP3 inflammasome (and thereby IL-1β production/secretion), these data together identify
protein nitration as a potential ‘smoking gun’ in the search for molecular mechanisms underpinning the chronic
neuroinflammation driving ALS pathogenesis.
Several pathogenic factors have been proposed to explain ALS pathogenic mechanisms [ 24 ]; these include increased
production of reactive oxygen species (ROS) [ 25 ] and nitroxyradicals responsible for protein tyrosine nitration
[ 23, 26, 27, 28 ]. The increase in ROS and NO is a hallmark of neuroinflammation, i.e. the occurrence of a
neuroinflammatory reaction consisting of activated glial cells, mainly microglia and astrocytes. Microglia, the
resident mononuclear phagocytes in the brain, are activated to protect the neuronal environment in response to
infection or damage. In these conditions, microglia acquire an amoeboid appearance, up-regulate oxidant molecules
such as NO and superoxide anion and secrete pro-inflammatory molecules such as TNFα and IL-1β [ 6 ]. For these
reasons, we used immortalized microglial cells from hSOD1(G93A) mice to study the mechanism leading to
neuroinflammation. Thus we exposed SOD1(G93A) overexpressing cells to LPS, a common inflammogen able to
induce neuroinflammation and reactive microgliosis in vivo and in vitro [ 21 ]. The exposure of SOD1(G93A)
microglial cells to LPS induced an increase in gene and protein expression of iNOS and gp91phox subunit of NOX2,
resulting in an increase in NO and ROS levels that consequently drove an increase in protein nitration. Several
reports link oxidative/nitrosative stress to ALS. Indeed, it has been described that NOX2 produces damaging ROS in
ALS [ 29, 30 ]; SOD1 mutations induce NADPH oxidase-dependent ROS production in microglia of SOD1(G93A)
mice, leading to motor neuron death [ 31, 32 ]; and the deletion of iNOS gene, significantly extends the lifespan of
SOD1(G93A) mice [ 33 ]. These data suggest that protein nitration may be one of the underlying causes of the
pathology.
It is worth noticing that, besides NOX2, mitochondria can also contribute to ROS generation. Indeed, in
neurodegenerative disorders, an increase in mitochondrial ROS generation, leading to NLPR3 activation, has been
reported [ 34, 35, 36 ].
We found that SOD1(G93A) microglial cells, activated by LPS stimulation, increased gene expression and protein
secretion of pro-inflammatory cytokines, including IL-1β. The IL-1 family of cytokines plays a role in host defense
and immune system regulation in inflammatory diseases [ 6 ]. IL-1β is produced as an inactive precursor (pro-IL-1β)
by microglia [ 6 ]. The biological effects of IL-1β follow the cleavage and activation of pro-IL-1β. The mature form
is then released and acts on the type I IL-1 receptor (IL-1RI) on the surface of responsive cells. Caspase1 is the key
protease essential for the processing of pro-IL-1β. The activity of caspase1 is regulated by its recruitment to
inflammasomes that follows an inflammatory stress [ 11 ]. NLRP3, the best-characterized inflammasome receptor
[ 10, 11 ], upon activation by many disease-associated molecules, oligomerizes with the adaptor ASC and caspase1 to
form the NLRP3 inflammasome. It is conceivable that activated SOD1(G93A) microglial cells have inflammasome
components to secrete mature IL-1β. We observed that all inflammasome receptors are indeed expressed in the
SOD1(G93A) microglial cell line and that LPS stimulation increased the gene and protein expression of NLRP3. By
binding to TLR4, LPS, via NF-κB, induces the expression of NLRP3 [ 10 ]. Moreover, in dendritic cells, TLR4
signaling is sufficient to trigger inflammasome activation [ 10, 37 ]. These reports suggest that TLR4 ligands are
active players in modulating inflammasome activation and that, depending on cell type, they can interact with
cell-specific target molecules and lead to an active inflammasome, even in the absence of other stimuli. Activated
SOD1(G93A) microglial cells also showed an active caspase1, indicating that all the steps needed to obtain a mature
IL-1β are present and active in this cell line. Indeed, LPS exposure caused an increase in the mature form of IL-1β.
Recently, the capacity to form a functional NLRP3 inflammasome and to secrete IL-1β, has been attributed to the
microglial compartment in the mouse brain [ 38 ]. On the other hand, NLRP3, ASC, active caspase1 and IL-18 are
concomitantly expressed in astroglial cells of spinal cord tissue samples from SOD1(G93A) mice and in sporadic
ALS patients [ 14 ].
Our work confirmed the presence of active caspase1 in spinal cord of SOD1(G93A) mice [ 14, 39 ] and causally
linked nitrotyrosyne levels to the activation of caspase1. Indeed, when the levels of nitrated proteins were reduced
by specific inhibition of iNOS and NOX2, the levels of active caspase1 were also reduced. It has been shown that
iNOS-positive activated glial cells were increased in transgenic SOD1(G93A) mice and that the reduction in the
levels of NO by අ-arginine administration, reduced motor neuron death and glial activation [ 40 ]. Moreover, the
pharmacological inhibition of NF-κB activation and iNOS expression, extended lifespan of transgenic mouse model
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of ALS [ 41 ]. Furthermore, genetic deletion and specific inhibition of NOX2 in the SOD1(G93A) mice was reported
to remarkably increase survival [ 29 ].
These results underpin that the increased levels of NO and ROS are potentially responsible for ALS pathogenesis
and/or progression. We propose that the noxious effects of oxidative/nitrosative stress are due to inflammasome
activation possibly due to nitration of NLRP3 itself. This hypothesis is in line with the results obtained in
intracelebral hemorrage where P2X7 receptor, which has peroxynitrite as a downstream signaling molecule, plays a
critical role in NLRP3 inflammasome activation [ 23 ]. It is to note that P2X7 receptor is involved in NLRP3
inflammasome activation [ 42 ]. Moreover, a blood-brain barrier permeable P2X7 receptor antagonist significantly
increased motor neuron survival and decreased lumbar spinal cord microgliosis, delayed the onset of the disease and
improved the motor performance of ALS mice. These effects have been related to the modulation of inflammatory
markers such as NF-κB, NOX2 and IL-1β [ 43 ].
Conclusion
Our results indicate that NOX2/iNOS-dependent formation of peroxynitrite, a downstream signaling component of
reactive microgliosis, may be a key trigger of caspase1 activation (Fig. 5 ). Thus, inhibition of peroxynitrite
formation could be a potential therapeutic target for ALS.
Fig. 5
Schematic  representation  of  peroxynitrite-induced  inflammasome  cascade  activation.  Neuroinflammatory  stimuli,
through NF-κB activation, induce in glial cells the expression of iNOS and gp91 phox subunit of NOX2 resulting in
increased levels of ROS and NO [44]. These species spontaneously react to form peroxynitrite, which, in turn, affect
inflammasome activation. This event leads to the cleavage of pro- to mature IL-1β, which upsurges the vicious circle of
inflammation
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